Form 4 Tracker
Xeris Biopharma Holdings, Inc.
XERS

11 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 3, 2026Jun 5 10:29 PMMarla PerskyDirector
Sale
15,500$5.90$91.4K126,500(D)

View →

Jun 4, 2026Jun 5 10:18 PMDawn HalkuffDirector
Sale
20,000$6.09$121.9K95,000(D)

View →

Jun 4, 2026Jun 5 10:18 PMBarbara-Jean Anne Bormann-KennedyDirector
Sale
16,000$6.09$97.5K126,500(D)

View →

Jun 4, 2026Jun 5 10:17 PMJohn JohnsonDirector
Sale
15,000$6.09$91.4K683,083(D)

View →

Jun 1, 2026Jun 2 10:05 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$6.06$101.0K1,176,506(D)

View →

May 1, 2026May 1 9:50 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$6.23$103.8K1,193,173(D)

View →

Mar 2, 2026Mar 4 10:28 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$6.25$104.1K1,226,507(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 5 10:39 PMGarheng KongDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:29 PMMarla PerskyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:18 PMDawn HalkuffDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:18 PMBarbara-Jean Anne Bormann-KennedyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:17 PMJohn JohnsonDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:16 PMJames Aloysius BradyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Mar 12, 2026Mar 16 10:11 PMKevin MccullochPresident and Chief Operating Officer
Option Exercise
48,898$4.0979,996(D)

View →

Mar 5, 2026Mar 6 12:18 AMSteven PieperChief Financial Officer
Option Exercise
41,927$5.930(D)

View →